Last price paid | 2.61 | |
Change | -8.74% [ -0.25 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 25.07.2024 17:20 |
Fixing | n.a. |
Settlement date | 16.01.2024 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +160.50% |
Year to date (YTD) | n.a. |
1 month | -27.90% |
3 months | +18.10% |
1 year | n.a. |
3 years | n.a. |
Issue price | 1.00 |
Underlying price on issue | 373.34 |
Premium | 0.01% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1305130531 |
Symbol | IMEDIZ |
Security | 130513053 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Meta Platforms N, US30303M1027 |
Underlying ISIN | US30303M1027 |
Funding level | 343.431600 |
Stop-loss level | 354.824500 |
Distance to stop-loss level | 22.39% |
Long/Short type | Long |
Subscription ratio | 40.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 11.01.2024 |
Premium | 0.99% |
Premium p.a. | n.a. |
Leverage | 3.86 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 113.859200 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
Lonza Group | 559.80 |
ROCHE GS | 277.50 |
Alcon AG | 81.98 |
NOVARTIS N | 96.93 |
SWISSCOM N | 534.50 |
Name | Price |
---|---|
Nestlé SA | 88.82 |
Partners Group Ho... | 1'175.50 |
ABB Ltd | 47.24 |
LOGITECH INT. | 77.70 |
Compagnie Financi... | 131.20 |